Aprea Therapeutics Competitors and Similar CompaniesClear all
Aprea Therapeutics's competitors and similar companies include UCB, Cipla, Livzon Pharmaceutical Group and Alembic Pharmaceuticals.
 Aprea Therapeutics Aprea Therapeutics is a pharmaceutical development company that is engaged in the discovery and development of anticancer compounds targeting tumour suppressor proteins. |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. |  Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products. |  Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. |  Alembic Pharmaceuticals Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates | |
Founding Date | Founding Date 2003 | Founding Date 1928 | Founding Date 1935 | Founding Date 1985 | Founding Date 2010 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Solna, SE HQ Boston, US | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more | Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN | Locations Vadodara, IN HQ Baska, IN Mumbai, IN Namthang, IN Vadodara, IN Vadodara, IN |
Employees | Employees 8 | Employees 9,052 | Employees 27,764 | Employees 9,067 | Employees 14,858 |
Valuation ($) | Valuation ($) 23.2 m | Valuation ($) 34.3 b | Valuation ($) N/A | Valuation ($) 4.2 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €7.4b (FY, 2025) | Revenue (est.) ₹277.1b (FY, 2026) | Revenue (est.) ¥11.7b (FY, 2025) | Revenue (est.) ₹73.4b (FY, 2026) |
Cost of goods | Cost of goods N/A | Cost of goods €1.4b (FY, 2025) | Cost of goods ₹97.2b (FY, 2026) | Cost of goods ¥4.1b (FY, 2025) | Cost of goods ₹19.8b (FY, 2026) |
Gross profit | Gross profit N/A | Gross profit €7.2b (FY, 2025) | Gross profit ₹184.4b (FY, 2026) | Gross profit ¥7.8b (FY, 2025) | Gross profit ₹54.1b (FY, 2026) |
Net income | Net income ($12.6m) (FY, 2025) | Net income €1.6b (FY, 2025) | Net income ₹38.7b (FY, 2026) | Net income ¥2.4b (FY, 2025) | Net income ₹6.7b (FY, 2026) |
Operating ⚠ | |||||
Products | Products N/A | Products N/A | Products 1.5 k (FY, 2024) | Products N/A | Products 145 (FY, 2024) |
For sources of this data, please see the company profile
View Company Profiles
UCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View companyCipla
HQ
Mumbai, IN
Employees
27,764
Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
View companyLivzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
9,067
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View companyAlembic Pharmaceuticals
HQ
Vadodara, IN
Employees
14,858
Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates
View company